ATRA

Atara Biotherapeutics, Inc. is a clinical-stage biotechnology company headquartered in South San Francisco, California, focused on allogeneic T-cell immunotherapy to treat cancer, autoimmune disorders, and viral infections. The company is advancing a compelling therapeutic platform that harnesses T-cells to meet significant unmet medical needs in complex diseases. With a robust pipeline of investigational therapies, Atara is well-positioned at the forefront of the immunotherapy landscape, aiming to improve patient outcomes and drive innovation in this critical sector of healthcare.